糖化血红蛋白及脂蛋白a水平与糖尿病并发心血管疾病的相关性分析被引量：1

下载PDF

导出

摘要目的探讨糖化血红蛋白和脂蛋白a水平与糖尿病患者并发心血管疾病的相关性。方法收集2011年1月-2014年12月我院门诊和住院确诊为糖尿病患者957例,在相同条件下检测Hb Alc和Lp(a),按其水平分为A、B、C组及正常人群329例为对照D组,统计分析四组并发心血管疾病的概率。结果 ABC三组并发心血管的阳性率明显高于对照组D组,其中B组和A组相对于C组,明显低于C组的阳性率(P<0.05),差异有统计学意义。结论糖化血红蛋白和脂蛋白a水平均是糖尿病并发心血管疾病的危险因素,同时检测两者水平比单独检测对预防糖尿病并发心血管疾病更具有临床价值。

作者陈达富陈玉莲郑兆富

机构地区台山市人民医院检验科

出处《实验与检验医学》 CAS 2015年第3期340-342,共3页 Experimental and Laboratory Medicine

关键词糖化血红蛋白脂蛋白A 糖尿病心血管疾病

分类号 R446.112 [医药卫生—诊断学] R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献10

1邓小军,李建梅,陈彬,郭健莲.2型糖尿病患者糖化血红蛋白与血脂测定的意义及相关性分析[J].实验与检验医学,2010,28(3):324-324. 被引量：6
2Rivera JJ ,Choi EK,Yoon YE, et a l.Association between increasing levels of hemoglobin Alc and coronary atherosclerosis in asymptomatic individuals without diabetes mellitus[J].Coron Artery Dis,2010,21(3):157-163.
3Carey VJ,Bishop L,Laranjo N,et al.Contribution of high plasma triglycefides and low high-density lipoprotein cholesterol to resid- ual risk of coronary heart disease after establishment of low-densi- ty lipoprotein cholesterol control[J].Am J Cardiol,2010,106(6):757- 763.
4宋银丹,段勇.糖化血红蛋白检测标准化的研究进展[J].实验与检验医学,2013,31(2):108-110. 被引量：20
5王德彬,赵茹妹,肖倩,张筱美.2型糖尿病患者糖化血红蛋白与脂蛋白a关系探讨[J].中国医药科学,2014,4(7):74-76. 被引量：1
6Scriver CR,Beaudet AL,SIy WS,et al.The metabolic and molecu- lar bases of inherited disease [M].8th ed.New York : McGraw-Hill, 2001:2753-2787.
7Matthews KA,Sowers MF,Derby CA,et al. Ethnic differences in cardiovascular risk factor burden among middle-aged women: study of women's health accoss the nation (SWAN)[J].Am Heart J, 2005,149(6):1066-1073.
8艾春芳.脂蛋白a的研究进展[J].中国社区医师（医学专业）,2012,14(23):5-5. 被引量：1
9Mottillo S,Filion KB,Genest J,et al.The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis [J].J Am Coil Cardiol, 2010,56(14) : 1113-1132.
10Fox CS,Coady S,Sorlie PD,et al.Trends in cardiovascular compli- cations of diabetes[J].JAMA,2004,292(20):2495-2499.

二级参考文献26

1王瑶,张树彬,李金梅,辛晓敏.老年糖尿病患者的糖化血红蛋白及血糖水平测定的意义[J].黑龙江医学,2006,30(10):774-775. 被引量：9
2林益振,陈彬彬.2型糖尿病患者血小板各参数和生化指标变化的研究[J].江西医学检验,2007,25(3):281-281. 被引量：1
3TUrner R C,Millns H,Neil H A,et al.Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus (UKPDS:23)[J].Brit Med J,1998,316(1):823-828.
4Laakso M,Lehto S,Penttila I,et al.Lipids and lipoprotein predicting coronary heart disease mortality and morbidity in patients with non-insulin dependent diabetes[J].Circulation,1993,88:1421-1430.
5许磊,李红.糖化血红蛋白升高与脂蛋白(a)相关性研究[J].中外健康文摘,2009,6(19):16-17.
6Lin J, Hu FB, Mantzoros C, et al.Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes[J].Diabetologia, 2010,53: 263-267.
7Scriver CR, Beaudet AL, Sly WS, et al.The metabolic and molecular bases of inherited disease[M].8th ed.New York: McGraw-Hill,2001 : 2753-2787.
8Matthews KA, Sowers MF, Derby CA, et al. Ethnic diffelnces in cardiovascular risk tactor burden among middle-aged women:study of women's health across the nation ( SWAN ) [J].Am Heart J,2005,149 (6): 1066-1073.
9Mottillo S, Filion KB, Genest J, et al.The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis[J].J Am Coil Cardiol,2010,56 ( 14 ): 1113-1132.
10Fox CS, Coady S, Sorlie PD, et al.Trends in cardiovascular complications of diabetes[J]. JAMA, 2004,292 ( 20 ) : 2495-2499.